Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients
Clinical trial NCT03876769 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03876769
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2027-10-19
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.